These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32065823)

  • 1. A prospective pharmacovigilance study in the infectious diseases unit of a tertiary care hospital.
    Karaismailoglu B; Saltoglu N; Balkan II; Mete B; Tabak F; Ozturk R
    J Infect Dev Ctries; 2019 Jul; 13(7):649-655. PubMed ID: 32065823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of pattern & distribution of adverse drug reactions in acute coronary syndrome patients in a tertiary care hospital.
    Mahadevappa M; Meher C; Pushpa NB; Kulkarni P; Poornima KS; Desai N
    Indian J Med Res; 2022 Jul; 156(1):111-121. PubMed ID: 36510903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study.
    Kurian J; Mathew J; Sowjanya K; Chaitanya KR; Ramesh M; Sebastian J; Narayanappa D
    Indian J Pediatr; 2016 May; 83(5):414-9. PubMed ID: 26916890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of Adverse Drug Reaction in the Medical Wards of a Teaching Hospital: A Prospective Observational Cohort Study.
    Peter JV; Varghese GH; Alexander H; Tom NR; Swethalekshmi V; Truman C; Kumar TR; Sivakumar T
    Curr Drug Saf; 2016; 11(2):164-71. PubMed ID: 26916785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun.
    Sharma PK; Misra AK; Gupta N; Khera D; Gupta A; Khera P
    Indian J Pharmacol; 2017; 49(5):390-395. PubMed ID: 29515280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
    Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
    BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse Drug Reaction Profile of Anticancer Agents in a Tertiary Care Hospital: An Observational Study.
    Shaikh SP; Nerurkar R
    Curr Drug Saf; 2022; 17(2):136-142. PubMed ID: 34433404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive monitoring of adverse drug reactions in nephrology unit of tertiary care teaching hospital.
    Kareem SA; Sridhar SB; Shetty MS
    Saudi J Kidney Dis Transpl; 2019; 30(5):1075-1083. PubMed ID: 31696846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and assessment of factors contributing to adverse drug reactions in wards of a tertiary care hospital, India.
    Haile DB; Ayen WY; Tiwari P
    Ethiop J Health Sci; 2013 Mar; 23(1):39-48. PubMed ID: 23559837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and nature of adverse drug reactions in elderly in-patients of two Indian medical college hospitals.
    Harugeri A; Parthasarathi G; Ramesh M; Guido S; Basavanagowdappa H
    J Postgrad Med; 2011; 57(3):189-95. PubMed ID: 21941055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reactions experience in a teaching hospital in Jordan.
    Alsbou M; Alzubiedi S; Alzobi H; Samhadanah NA; Alsaraireh Y; Alrawashdeh O; Aqel A; Al-Salem K
    Int J Clin Pharm; 2015 Dec; 37(6):1188-93. PubMed ID: 26286340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence.
    Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P
    Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacovigilance Study of Anticancer Drugs in a Tertiary Care Teaching Hospital in North India: A Retrospective Study.
    Kumar R; Jindal A; Garg P; Kaur A; Kumar S; Tilak Raj R; Singh S
    Cureus; 2023 Sep; 15(9):e44984. PubMed ID: 37822427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients.
    Vázquez-Alvarez AO; Brennan-Bourdon LM; Rincón-Sánchez AR; Islas-Carbajal MC; Huerta-Olvera SG
    BMC Pharmacol Toxicol; 2017 Dec; 18(1):79. PubMed ID: 29216902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions in a pulmonary teaching hospital: incidence, pattern, seriousness, and preventability.
    Baniasadi S; Fahimi F
    Curr Drug Saf; 2011 Sep; 6(4):230-6. PubMed ID: 22129318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of adverse drug reactions causing admission to an intensive care unit.
    Rojas-Velandia C; Ruiz-Garzón J; Moscoso-Alcina JC; Vallejos-Narvaéz Á; Castro-Canoa J; Bustos-Martínez Y; Flórez-Cutiva M; Contreras-Muñoz M; Gómez-Gil JC; Calderón-Ospina CA
    Br J Clin Pharmacol; 2017 May; 83(5):1134-1140. PubMed ID: 27905143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department.
    Olivier P; Boulbés O; Tubery M; Lauque D; Montastruc JL; Lapeyre-Mestre M
    Drug Saf; 2002; 25(14):1035-44. PubMed ID: 12408734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study.
    Angamo MT; Curtain CM; Chalmers L; Yilma D; Bereznicki L
    PLoS One; 2017; 12(10):e0186631. PubMed ID: 29036230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns, predictors and preventability of adverse drug reactions in the coronary care unit of a tertiary care hospital.
    Devi P; Kamath DY; Anthony N; Santosh S; Dias B
    Eur J Clin Pharmacol; 2012 Apr; 68(4):427-33. PubMed ID: 22009191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.